In Practice: Clinical Insights
Choose from the two live presentation times below. Click the register button on the Microsoft Teams page to complete the form. A meeting link will be emailed to you upon registration.
Opioid Use Disorder:
Evaluating Risk of Return to Use
Date: Tuesday, October 28, 2025
Supporting patients with opioid use disorder (OUD) requires ongoing vigilance, as the risk of return to use remains a critical challenge even during treatment. This webinar explores evidence-based insights and practical strategies to help clinicians better understand, detect, and address recurrence risk. Special attention will be given to the role of medication adherence testing as a valuable tool for patient monitoring and treatment optimization.
Learning Objectives
By the end of this session, participants will be able to:
- Define the scope of the current opioid epidemic and its implications for clinical care.
- Characterize the risk of return to use in patients receiving treatment for OUD.
- Identify factors that influence sustained recovery versus relapse.
- Examine real-world Aegis data on return to use detection
Join us to gain actionable insights that will inform clinical decisions and support long-term recovery.
What Did My Patient Actually Take?
Potential causes of unexpected results in definitive testing
Identifying the Use of Marijuana THC and Other Natural Cannabinoids
Date: December 15, 2023
Length: 20 minutes
What Did My Patient Actually Take? An Overview of Dextromethorphan/Levorphanol Results
Date: December 17, 2020
Length: 12 minutes
What Did My Patient Actually Take? An Overview of Benzodiazepine Results
Date: December 17, 2019
Length: 12 minutes
What Did My Patient Actually Take? A Review of Opioid Results Interpretation
Date: November 21, 2019
Length: 12 minutes
What Did My Patient Actually Take? An Overview of Marijuana Results
Date: October 24, 2019
Length: 8 minutes
What Did My Patient Actually Take? Unexpected Causes of Cocaine Results
Date: August 29, 2019
Length: 15 minutes
What Did My Patient Actually Take? An Overview of Amphetamine Results
Date: June 27, 2019
Length: 13 minutes
What Did My Patient Actually Take? An Overview of Methamphetamine Results
Date: July 17, 2019
Length: 13 minutes
Emerging Drug Trends
Stay up to date on the latest illicit & designer drug trends
2025 Mid-Year Update on Novel Psychoactive Substances (NPS) Trends
Date: August 21, 2025
Length: 25 minutes
Prevalent Adulterants Found in the Illicit Drug Supply
Date: April 30, 2025
Length: 15 minutes
Novel Psychoactive Substances 2024: A Year in Review
Date: February 18, 2025
Length: 15 minutes
New Nitazene Data – Ongoing Evaluation of an Emerging Threat
Date: June 25, 2024
Length: 15 minutes
Novel Psychoactive Substances: Newly Identified Threats Detected in the Second Half of 2022
Date: March 28, 2023
Length: 25 minutes
Novel Psychoactive Substances: What is Xylazine?
Date: January 24, 2023
Length: 15 minutes
Emerging Data on Novel Psychoactive Substances and Clinical Effects
Date: September 23, 2020
Length: 15 minutes
Clinical Considerations
Learn more about circumstances that may impact testing protocols and result interpretation
Opioid Use Disorder: Evaluating Risk of Return to Use
Date: October 28, 2025
Time: 9:00am or 1:00pm (Central Time)
Length: 15 minutes
New Additions to the Aegis Behavioral Health Testing Menu
Date: June 26, 2025
Length: 15 minutes
Responding to the Unexpected: Harm Reduction and Improved Outcomes
Date: October 29, 2024
Length: 15 minutes
Telemedicine Improvements After Epidemics Collide
Date: August 22, 2024
Length: 15 minutes
Managing Neonatal Abstinence Syndrome: Screening and Medication Monitoring
Date: May, 25, 2023
Length: 15 minutes
Behavioral Health: Why Monitor Patients for Medication Adherence
Date: August 31, 2022
Length: 15 minutes
Cases of Unusual Buprenorphine Concentrations in Urine Drug Tests: What Does This Mean and Clinical Implications?
Date: August 31, 2021
Length: 15 minutes
Interpretation of Buprenorphine Results: Considerations for Dosage Form and Specimen Type
Date: May 20, 2021
Length: 15 minutes
Evaluating Drug Interactions
Discusses the use of definitive testing for interacting substances and how the results can impact patient care
Spotlight on Potential Interactions Involving Behavioral Health & Substance Use Disorder Medications
Date: June 27, 2023
Length: 15 minutes
InterACT Rx Pharmacodynamic Insights: A Brief Look at QTc Prolongation, Serotonin Syndrome, and Tardive Dyskinesia
Date: October 25, 2022
Length: 20 minutes
Complexities of Risk Assessment: Opioids, Drug Interactions, & Designer Benzodiazepines
Date: September 28, 2022
Length: 17 minutes
InterACT Rx: A Look at Clinical Utility Through a Discussion of Interactions Found
Date: June 24, 2022
Length: 15 minutes
Enhanced DDI Identification and Patient Care with InterACT Rx
Date: March 15, 2019
Length: 27 minutes
